Specialty Pharma Journal Specialty, Precision & Technology

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that a global Phase III …

DAEJEON, South Korea–(BUSINESS WIRE)–LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080) announced today that it has entered a research …

[3/21/2019] The U.S. Food and Drug Administration is alerting health care professionals, oncology clinical investigators and …

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced further positive data from the DREAMM-1 study of patients …

ORANGEBURG, New York, March 21, 2019 /PRNewswire/ — Impulse Dynamics, developer of the implantable Optimizer® …

SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced top-line …

CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) …

Oxford, UK,21 March 2019: Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today …

INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced findings of a three-year follow-up study comparing …

CAMBRIDGE, Mass. and BASEL, Switzerland, March 21, 2019 /PRNewswire/ — Enzyvant, a biopharmaceutical company focused …

PARIS & NEW YORK–(BUSINESS WIRE)–Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to …

BOSTON & SOLNA, Sweden–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Affibody AB today announced a partnership to …

KENILWORTH, N.J., and SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering …

Darmstadt, Germany and New York, US, March 19, 2019 – Merck KGaA, Darmstadt, Germany, which …